Status:
COMPLETED
A Tele-Health Symptom Management Program for Patients With Heart Failure: Pall-Heart
Lead Sponsor:
University of Virginia
Collaborating Sponsors:
University of Kentucky
Conditions:
Heart Failure
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Heart failure is common in adults and is the most common hospital diagnosis in older adults. Patients with heart failure suffer numerous distressing symptoms daily. Although palliative care can improv...
Eligibility Criteria
Inclusion
- Heart failure with reduced ejection fraction or Heart failure with preserved ejection fraction as seen by problem list in the EMR, is a patient in the heart failure clinic, or general cardiology clinic.
- ability to read, write and understand English;
- agree to participate and give informed consent;
- 19 years of age and older;
- telephone access;
- and NYHA class I-III with no changes in medications in 30 days (i.e. medical therapy is optimized).
Exclusion
- are pregnant and/or breast feeding (self-reported)
- have a history of non-adherence with medications (as described by their provider or medical record);
- have had a hospitalization within the last 3 months for HF;
- have unstable angina; CABG, MI or biventricular pacemaker less than 6 weeks prior;
- have orthopedic impediments to stretching exercise;
- have severe COPD with a forced expiratory volume in one second less than 1 liter as measured by spirometry;
- have severe stenotic valvular disease;
- have a history of resuscitated sudden cardiac death without subsequent placement of an implantable cardioverter defibrillator;
- exercise more than 3 times weekly; currently engage in yoga at least 1 time per week;
- have cognitive impairment (as measured by the Mini-Cog)
- are living in a nursing home
- history of pulmonary arterial hypertension (PASP\>60mmHg)
- other serious life-limiting co-morbidity, e.g. end stage cancer
- post-heart transplant (s/p OHT) or Left Ventricular Assist Device (LVAD)
- New York Heart Association Functional Class IV
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04120857
Start Date
June 1 2019
End Date
September 30 2020
Last Update
November 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia
Charlottesville, Virginia, United States, 22908